Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Large crowd in the recruiters row on the RSNA expo floor. There was a record number of recruiters at RSNA this year as the radiologist shortage begins to hurt many healthcare systems. The shortage was also brought up in nearly all discussions Radiology Business has at RSNAS 2023. #RSNA #RSNA23 #RSNA2023

4 key trends in radiology at RSNA 2023

The rapidly growing shortage of radiologists and technologists was by far the biggest concern discussed across the Radiological Society of North America meeting.

Philips Vanderbilt Carbon Emissions Warning

How radiology departments can decarbonize, save money

Philips and Vanderbilt University Medical Center have released findings from their efforts to reduce waste in the hospital's radiology department.

Thumbnail

Jury convicts radiology business owner in imaging-contrast kickback scheme

Neurosurgeon Payam Toobian, MD, oversaw a scam in which two physicians would receive gift cards and cash in exchange for referrals to his imaging center.

artificial intelligence money finance acquisition

Aidoc invests $30M to create first-of-its-kind artificial intelligence model

The new AI effort will initially focus on three key areas, including accelerating the development of robust imaging algorithms, leaders said at RSNA 2023. 

Bankruptcy judge approves radiology provider Akumin’s plan to go private under new ownership

Under terms of the deal, lender Stonepeak will swap some $470 million in debt for ownership in the reorganized business.

Johnson & Johnson acquires medical device company behind new LAA technology for $400M

The deal could also include additional clinical and regulatory milestone payments in the years ahead.

Cardiologist receives $7M for 5-year study to boost care for heart failure patients

The research will focus on ways to improve the utilization of electronic resources among heart failure patients and the doctors who treat them.

Thumbnail

Avidity Biosciences inks drug discovery deal worth up to $2.3B with industry heavyweight

Avidity Biosciences, a San Diego-based biopharmaceutical company, is expanding its ongoing collaboration with Bristol Myers Squibb to identify new cardiovascular therapies.